Clinical Trials Browser

OTHER × Neoplasms × Dasatinib × Clear all

NCT04733534 2026-01-20

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

Phase 2 Active not recruiting

110 enrolled

Frailty, Neoplasms

NCT01636908 2021-04-15

ICK

Phase NA Completed

43 enrolled

Tumor-Agnostic

Neoplasms

NCT01999985 2020-11-27

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

Phase 1 Completed

25 enrolled 10 charts

Thoracic

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Pleural Diseases, Pleural Effusion, Pleural Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Pleural Effusion, Malignant

NCT00820170 2019-08-13

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194

Phase 1/2 Completed

55 enrolled 19 charts

Breast

Breast Neoplasms, Neoplasms